Skip to main content

Table 3 Re-classification of histotypes

From: Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

Original classification: Revised Classification Total original
BOT HGSC EC LGSC CCC MC other unknown
HGSC 1 1131 (95%) 14 30 9 2 3 1 1191
EC 1 43 267 (84%) 0 0 2 3 1 317
LGSC 9 19 0 69 (72%) 0 0 0 0 96
CCC 1 4 4 0 248 (96%) 0 0 0 257
MC 10 6 10 0 0 84 (73%) 6 0 116
other 1 7 1 1 1 0 11(55%) 0 20
unknown 2 36 0 3 1 0 0 6 (NA) 48
Total after reclassification 25 1246 296 102 259 88 21 8 2045
  1. (%) represent the % of original cases correctly classified, BOT Borderline Ovarian Tumor, HGSC High-Grade Serous Carcinoma, EC Endometrioid Carcinoma, LGSC Low-Grade Serous Carcinoma, CCC Clear Cell Carcinoma, MC Mucinous carcinoma